IL6 and Familial prostate cancer: As for possible reasons for the study by Mandal et al presenting the source of significant heterogeneity, we speculated that their finding about the opposite effects of IL-6 rs1800795 polymorphism on prostate cancer risk in 2 different descent groups itself might partly contribute to the occurrence of the heterogeneity.